|
HS Code |
192815 |
| Name | Bilobol |
| Iupac Name | 5-[(Z)-Pentadec-8-enyl]benzene-1,3-diol |
| Common Name | Bilobol |
| Molecular Formula | C21H34O2 |
| Molecular Weight | 318.50 g/mol |
| Cas Number | 4175-93-1 |
| Appearance | Oily liquid |
| Solubility | Soluble in organic solvents |
| Structure Type | Alk(en)ylresorcinol |
| Source | Ginkgo biloba kernels |
| Bioactivity | Irritant; cytotoxic properties |
| Uses | Primarily of research interest |
| Smiles | CCCCCCC/C=C/CCCCCCCCC1=CC(=CC(=C1)O)O |
As an accredited Bilobol (5-[(Z)-Pentadec-8-Enylo] Resorcinol) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Bilobol (5-[(Z)-Pentadec-8-enyl] resorcinol) is supplied in a sealed amber glass vial containing 1 gram, labeled for laboratory use. |
| Shipping | Bilobol (5-[(Z)-Pentadec-8-enyl] resorcinol) is shipped in tightly sealed, chemically resistant containers under ambient or specified cool conditions to prevent degradation. All shipments comply with hazardous material regulations, include safety labels, and are accompanied by relevant documentation such as the Safety Data Sheet (SDS) and handling instructions. |
| Storage | Bilobol (5-[(Z)-Pentadec-8-enyl]resorcinol) should be stored in a tightly sealed container, protected from light and moisture. Keep it in a cool, dry place at 2–8°C (refrigerator temperature) and away from incompatible materials such as strong oxidizers. Proper labeling and handling with personal protective equipment are advised to ensure safety and chemical stability. |
Competitive Bilobol (5-[(Z)-Pentadec-8-Enylo] Resorcinol) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615380400285 or mail to sales2@liwei-chem.com.
We will respond to you as soon as possible.
Tel: +8615380400285
Email: sales2@liwei-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Every new molecule that comes to our production line brings along a challenge. For years, we witnessed shifts in industry preferences, watched trends come and go, and spoke often with researchers who hinted at the potential of naturally derived compounds. Our production of Bilobol—scientifically known as 5-[(Z)-Pentadec-8-Enylo] Resorcinol—rose from growing demand in the pharmaceutical, cosmetic, and specialty chemical sectors for molecules capable of outperforming older, less targeted alternatives. Recognized for its unique resorcinol backbone with a long, unsaturated side chain, Bilobol doesn’t simply follow the crowd of conventional resorcinols. Its structure unlocks reactivity and stability, opening up formulations that had once stumped development chemists.
Making Bilobol is not a process that tolerates improvisation. We control every variable tightly, from the sourcing of fatty acid feedstocks through each purification stage. The Z-configuration at the 8-enyl position sometimes demands additional vigilance. If purity drops below optimal thresholds, downstream reactions get rocky. Experience has taught us that even minuscule variations can influence a batch’s behavior, especially for pharmaceutical developers running exacting syntheses. Every week, we tune reaction conditions and analyze intermediate streams, not because regulations say so, but because poor control wastes time, material, and trust. Our consistency gets validated not only in our in-house analytics but also in the feedback we gather from formulators who push Bilobol’s boundaries further with each new project.
Many chemical plants churn out resorcinol derivatives, but not every facility can generate the kind of long-carbon chain with a defined (Z) double bond you get in Bilobol. This feature does more than check a box on a chemical certificate. It creates a new landscape for reactivity, handling, and final product properties. Cosmetic chemists leverage this structure to anchor actives in lipid-based bases. Pharmaceutically, a long-chain substituted resorcinol brings new possibilities for membrane permeability and biological activity—attributes that frequently escape simpler resorcinols or alkylphenols.
Standard resorcinols find their use in photographic chemicals, dyes, or some medical applications, but they lack the versatility that Bilobol’s alkylene chain brings to the table. Products with shorter alkyl groups or no unsaturation tend to be less capable of mimicking or disrupting biological lipid systems. After close work with product developers and researchers, we learned that tailoring the chain length and degree of unsaturation matters. Bilobol’s structure earns it a place in certain studies on antioxidant properties, antimicrobial agents, and plant-based additives where simpler molecules can’t compete.
Chemists who work with Bilobol expect more than a name. Each batch is produced with a purity that we routinely confirm by chromatographic and spectroscopic means. Slight impurities, often unavoidable in bulk organic synthesis, remain tightly controlled so that downstream interpretations remain accurate. Moisture levels and stabilizer use draw careful monitoring, since prolonged storage can alter compound integrity. The off-white to pale yellow appearance, mild aroma, and defined melting range are not marketing terms, but realities that our team faces and records batch after batch. Bilobol ships in light-protected containers that match storage recommendations, because ignoring small details can unravel months of science downstream.
In the skincare arena, Bilobol steps out of the shadows of generic resorcinols. Its integration into creams and serums goes beyond fragrance or filler. Clients reported increased stability in emulsions where the unsaturated chain anchors the molecule within lipid layers—a claim often confirmed by side-by-side shelf life studies. Pharmaceutical R&D teams explore its antimicrobial and skin penetration capabilities, taking cues from academic work on related compounds. In the lab, Bilobol shows compatibility with a wide array of excipients, instead of clumping or separating during blending trials.
Industrial formulators see more than chemistry—cost and supply chain reliability come into play. We commit to safeguarding both. Long-term contracts with raw material suppliers and investment in redundancy kept us shipping through volatile seasons when other specialty chemicals dried up. Development partners often exchange technical notes with our team, revisiting data from previous batches to drive process improvements at both ends of the supply chain.
Experienced chemists sooner or later face the limits of generic resorcinols or phenolic analogs. Bilobol extends into new use-cases where others fall short. The extended unsaturated chain imparts solubility properties close to those of natural amphiphiles. Contrast this with standard resorcinol, which remains soluble only in polar environments and can limit applications that need oil-phase compatibility. The structure also buffers the compound’s reactivity, avoiding excessive volatility or oxidation that plagues plain resorcinol and related short-chain derivatives.
We spent years benchmarking Bilobol against common industry alternatives. Crude alkylresorcinols often display batch-to-batch inconsistency, creating headaches for regulatory submissions. Phenolic substances derived from fossil sources sometimes raise concerns for sustainability and traceability. Bilobol’s raw materials trace back to renewable plant sources—a fact that excites clients driven by consumer demand for ethical production. Our supply chain faces regular audits, and every critical checkpoint is shaped by lessons drawn from previous industry disruptions.
No modern chemical product arrives without hurdles. Early Bilobol projects revealed persistent resource issues—especially when scaling up Z-enylation of the resorcinol core. Reaction kinetics forced us to try new catalyst systems, batch reactors needed upgrades, and quality control staff earned every late night in the analytics lab. The feedback loop between process chemists and formulators steered most of our improvements. As new product demands emerged, small tweaks in temperature, solvent ratios, and purification steps reduced byproduct formation and stabilized performance.
One lesson endured: successful production relies less on a single “magic ingredient” than on sweat, documentation, and data. We tweaked reactor protocols, reevaluated solvent recovery strategies, and worked closely with external partners to push yields higher without raising impurity risk. These operational lessons filtered back to logistics as well. Shipping inevitably threatens fragile organics; our team’s experience with proper handling minimizes multi-point degradation, showing up as fewer product returns and better batch reproducibility for our customers.
Selling Bilobol means building relationships that go past the invoice. End-use customers approach us for more than certifications. They ask about process optimization, formulation tips, and technical support during product development. Application chemists on our staff share direct guidance, such as optimal dissolution protocols or compatible stabilizers. Questions about stability under heat, pH, and light variations come backed by our own shelf life and accelerated storage studies.
We welcome repeat feedback from clients who put Bilobol through demanding tests. Specialty chemicals only thrive if every batch inspires confidence—whether in a startup lab exploring new antimicrobial agents or a multinational corporation planning to scale up novel skincare lines. We remain transparent with any process improvement or formulation discovery, keeping channels open for collaboration in both directions.
Bilobol’s appeal stretches across boundaries, requiring strict attention to regional and international laws. Clients often point out the ease of their own audits due to our approach—meticulously maintained batch records, traceability to source crops, and continual updates to technical dossiers. Experience taught us the value of proactive reporting, rather than waiting for questions to snowball as a project gains speed. Material safety, handling protocols, and recommended personal protective equipment are all vetted by both our compliance group and trusted third-party auditors. This transparency gave our downstream partners an edge in their own regulatory submissions, making product launches smoother.
We work with a diverse set of customers: multinational pharmaceutical manufacturers, boutique cosmetics brands, and academic researchers pushing natural resorcinols in new therapeutic applications. Each partnership sharpens our understanding of both strengths and limits of the compound. A research group might come to us with a new idea for Bilobol in food preservation. Cosmetic companies push us to refine purity and profile cost structures to match tough industry requirements. We see patterns emerge with each collaborative effort—the feedback cycles drive real improvements in yield, reproducibility, and downstream usefulness.
A customer once shared their frustration with mixed shipments of resorcinol analogs from other factories. Every inconsistent batch created bottlenecks and hours of extra validation. Bilobol from our manufacturing lines counters this problem. Years of hands-on work led us to layer in robust quality checks at each segment of production and distribution. Retention samples, third-party verifications, and internal stress-tests detect even the smallest deviations early. As a chemical manufacturer, cutting corners on verification only adds to costs later. Experience keeps the bar high and trust intact.
Innovation never stands still. Industry demand for specialty resorcinols grows alongside consumer expectations for sustainable sourcing and trackable origin stories. New applications arrive steadily: agricultural bioactives, food-preserving agents, antiviral additives, and more. We watch these fields closely, investing in R&D to evaluate and validate Bilobol’s fit. Each new request prompts further development in both testing methods and manufacturing scale.
The movement toward greener, bio-based chemicals aligns with our long-term goals. Many upstream synthetic footprints shrink through process redesign and smarter use of renewable materials. The carbon chain in Bilobol, biologically sourced and crafted under controlled conditions, positions it favorably on regulatory radar and among companies seeking to shrink their own environmental impact.
Bringing a specialty molecule like Bilobol onto a new product’s ingredient list presents hurdles. Companies share their hesitation over historical data, regulatory precedent, and cost modeling. Early conversations often cover all three at once, so transparent communication matters. Our technical support group collaborates directly, reviewing possible incompatibilities and helping to forecast scale-up realities. If an end-use fails initial stability screens, we join the troubleshooting instead of deferring to a generic FAQ.
The main opportunity lies in Bilobol’s underexplored potential. Emerging studies on its antimicrobial and antioxidant properties help justify new investments, as the market seeks innovations that outrun existing synthetic preservatives or actives. Regular attendance at technical conferences and maintaining direct outreach to academic teams keep us current—and sometimes open doors to niches we hadn’t previously considered.
Laboratory audits sometimes reveal the weak link in a specialty chemical’s origin story. We structure every part of Bilobol’s production for traceability. Detailed batch records align with our raw material procurement, so whether a client wants details on feedstock harvesting or post-synthesis purification, we stand ready. We invest in upstream relationships for real data, not generic claims. This approach has solved problems in the past, such as quickly tracing a subtle odor batch back to a specific feedstock lot and isolating the issue before shipment.
Manufacturing Bilobol, day after day, demands more than a single innovation or laboratory technique. To keep high standards, we foster a culture that values learning and improvement. Our analysts, plant operators, and research staff meet regularly, swapping reports and technical insights that cross traditional department boundaries. This culture translates directly to the product’s reliability on the market, and keeps us nimble in the face of regulatory or supply chain shifts.
We never treat any batch as trivial, nor any customer as routine. Everyone here understands that today’s reliability earns tomorrow’s trust. Product managers and chemists at our clients’ labs keep us honest with their feedback, and we treat their insights as main drivers for continuous improvement. The steady growth we’ve seen in Bilobol’s adoption validates this approach—step by step, feedback by feedback, run after run.
Where does Bilobol go from here? As new needs and formulations spring up, we find opportunities to adapt. Each call, each formulation challenge, each industry shift sharpens our commitment to practical, robust chemical manufacturing. Where others favor generic or lowest-cost solutions, our investment in detail, listening, and relentless improvement makes a difference. Through open communication and years of ground-level experience, we deliver more than a unique resorcinol—we remain a partner in every customer’s own story of innovation and discovery.